These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36381312)

  • 1. HOXC10 promotes carboplatin resistance of ovarian cancer by regulating ABCC3.
    Li Y; Lei H; Hai R; Shu G; Yan W; Yin G
    Am J Cancer Res; 2022; 12(10):4602-4621. PubMed ID: 36381312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXC10 promotes tumour metastasis by regulating the EMT-related gene Slug in ovarian cancer.
    Peng Y; Li Y; Li Y; Wu A; Fan L; Huang W; Fu C; Deng Z; Wang K; Zhang Y; Shu G; Yin G
    Aging (Albany NY); 2020 Sep; 12(19):19375-19398. PubMed ID: 32897245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1β-mediated HOXC10 Overexpression Promotes Hepatocellular Carcinoma Metastasis by Upregulating PDPK1 and VASP.
    Dang Y; Chen J; Feng W; Qiao C; Han W; Nie Y; Wu K; Fan D; Xia L
    Theranostics; 2020; 10(8):3833-3848. PubMed ID: 32206125
    [No Abstract]   [Full Text] [Related]  

  • 4. Erratum: HOXC10 promotes carboplatin resistance of ovarian cancer by regulating ABCC3.
    Li Y; Lei H; Hai R; Shu G; Yan W; Yin G
    Am J Cancer Res; 2024; 14(1):403-406. PubMed ID: 38323296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell cycle transition through transcriptional repression of p21.
    Lin ZH; He JM; Lai SC; Ding N; Jiang Y; He XK; Liu XS; Huang ZH
    Neoplasma; 2022 Dec; 69(6):1303-1313. PubMed ID: 36264773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXC10 promotes cell migration, invasion, and tumor growth in gastric carcinoma cells through upregulating proinflammatory cytokines.
    Li J; Tong G; Huang C; Luo Y; Wang S; Zhang Y; Cheng B; Zhang Z; Wu X; Liu Q; Li M; Li L; Ni B
    J Cell Physiol; 2020 Apr; 235(4):3579-3591. PubMed ID: 31552684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis.
    Xia X; Li Z; Li Y; Ye F; Zhou X
    J Gynecol Oncol; 2022 Nov; 33(6):e81. PubMed ID: 36335987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway.
    Han T; Chen T; Chen L; Li K; Xiang D; Dou L; Li H; Gu Y
    Cell Death Dis; 2023 Sep; 14(9):606. PubMed ID: 37709768
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Yu J; Zhang X; Ma Y; Li Z; Tao R; Chen W; Xiong S; Han X
    Cancer Biother Radiopharm; 2021 Feb; 36(1):95-105. PubMed ID: 32552008
    [No Abstract]   [Full Text] [Related]  

  • 10. HOXC10 overexpression promotes cell proliferation and migration in gastric cancer.
    Kim J; Bae DH; Kim JH; Song KS; Kim YS; Kim SY
    Oncol Rep; 2019 Jul; 42(1):202-212. PubMed ID: 31115563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of HOXC10 promotes angiogenesis in human glioma via interaction with PRMT5 and upregulation of VEGFA expression.
    Tan Z; Chen K; Wu W; Zhou Y; Zhu J; Wu G; Cao L; Zhang X; Guan H; Yang Y; Zhang W; Li J
    Theranostics; 2018; 8(18):5143-5158. PubMed ID: 30429891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/
    Jia X; Wei L; Zhang Z
    Front Genet; 2021; 12():616220. PubMed ID: 33995475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids.
    Wang H; Zhang Y; Miao H; Xu T; Nie X; Cheng W
    Cancer Cell Int; 2024 Jan; 24(1):42. PubMed ID: 38273320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXC10 promotes esophageal squamous cell carcinoma progression by targeting FOXA3 and indicates poor survival outcome.
    He X; Wang H; Wang R; Li Y; Li S; Cao X; Xu J
    Heliyon; 2023 Oct; 9(10):e21056. PubMed ID: 37876483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma.
    Li S; Zhang W; Wu C; Gao H; Yu J; Wang X; Li B; Jun Z; Zhang W; Zhou P; Shi J; Wang L; Gao Y; Li S; Tao B
    FEBS J; 2018 Jun; 285(12):2278-2291. PubMed ID: 29676849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXC10 up-regulation promotes gastric cancer cell proliferation and metastasis through MAPK pathway.
    Guo C; Hou J; Ao S; Deng X; Lyu G
    Chin J Cancer Res; 2017 Dec; 29(6):572-580. PubMed ID: 29353980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.
    Ricciardelli C; Ween MP; Lokman NA; Tan IA; Pyragius CE; Oehler MK
    BMC Cancer; 2013 Oct; 13():476. PubMed ID: 24124770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2.
    Song Z; Liao C; Yao L; Xu X; Shen X; Tian S; Wang S; Xing F
    Cancer Gene Ther; 2023 Apr; 30(4):596-607. PubMed ID: 36494581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXC10 Expression Supports the Development of Chemotherapy Resistance by Fine Tuning DNA Repair in Breast Cancer Cells.
    Sadik H; Korangath P; Nguyen NK; Gyorffy B; Kumar R; Hedayati M; Teo WW; Park S; Panday H; Munoz TG; Menyhart O; Shah N; Pandita RK; Chang JC; DeWeese T; Chang HY; Pandita TK; Sukumar S
    Cancer Res; 2016 Aug; 76(15):4443-56. PubMed ID: 27302171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway.
    Wang G; Li L; Li Y; Zhang LH
    Phytomedicine; 2023 Jan; 109():154571. PubMed ID: 36610147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.